Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
158,075
-
Shares change
-
+14,058
-
Total reported value, excl. options
-
$1,139,856
-
Value change
-
+$101,771
-
Number of buys
-
5
-
Number of sells
-
2
-
Price
-
$7.21
Institutional Holders of KAZIA THERAPEUTICS LTD - SPONSORED ADS (KZIA) as of Q3 2025
As of 30 Sep 2025 KAZIA THERAPEUTICS LTD - SPONSORED ADS (KZIA) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 158,075 shares of stock of the company.
Largest 10 holders included Dauntless Investment Group, LLC, BARCLAYS PLC, Rockefeller Capital Management L.P., UBS Group AG, CITIGROUP INC, RHUMBLINE ADVISERS, MORGAN STANLEY, Arax Advisory Partners, MAI Capital Management, and OSAIC HOLDINGS, INC..
This table shows 11 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.